EN
TradingView
Ticker Trading Ideas Educational Ideas Scripts People
Profile Profile Settings Account and Billing Referred friends Coins My Support Tickets Help Center Sign Out Upgrade Upgrade now 30-day Free Trial Start free trial Upgrade plan Pay nothing extra Upgrade early Get 6 months free Use last chance Get a month for $1
Markets US Stocks Health Technology Biotechnology

ABCELLERA BIOLOGICS INC
ABCL NASDAQ

ABCL
ABCELLERA BIOLOGICS INC NASDAQ
Trade now
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Trade now
Overview
Ideas Technicals Financials

ABCL Stock Chart

Ideas

Videos only
ABCL - SARS News - Falling Wedge
ABCL
, 15
Long
ABCL: ABCL - SARS News - Falling Wedge

Actually a good chart position / funadmentals iBorrowdesk.com the short fee just doubled from 17 to 35 past 15 minutes. News 15 min ago...

Possible plays
ABCL
, 30
ABCL: Possible plays

Needs to break $45 to retest the high other wise dropping to mid 20$ range.

ABCL setting up a cup and handle
ABCL
, 1D
ABCL: ABCL setting up a cup and handle

ABCL breakout above $57

abcl
ABCL
, 60
ABCL: abcl

ABCL

ABCL
ABCL
, 30
Long
ABCL: ABCL

Top IPO pick 2021. Long / Avg. $38

ABCL - Buy @44, Take Profit @58-60$
ABCL
, 1D
Long
ABCL: ABCL - Buy @44, Take Profit @58-60$

AbCellera might just be the one to surpass all recent IPOs and it is not getting the attention it deserves.

ABCL
ABCL
, 120
Long
ABCL: ABCL

HOT>

Technicals

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Health Technology
Industry: Biotechnology
AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

News

Home Stock Screener Forex Screener Crypto Screener Economic Calendar About Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter
Profile Profile Settings Account and Billing Referred friends Coins My Support Tickets Help Center Private Messages Chat Sign Out
Upgrade Upgrade now 30-day Free Trial Start free trial Upgrade plan Pay nothing extra Upgrade early Get 6 months free Use last chance Get a month for $1